Michael P. Flaherty, M.D., Ph.D., FSCAI, FACC

Michael P. Flaherty, M.D., Ph.D., FSCAI, FACC

Michael P. Flaherty M.D., Ph.D.

Michael P. Flaherty M.D., Ph.D., FSCAI, FACC

  • Associate Professor of Medicine, Physiology and Biophysics
  • Director, Adult Structural Interventional Program
  • Director of Research, Interventional Cardiology Program
UofL Physicians Outpatient Center
401 East Chestnut Street, Ste. 310
Louisville, KY 40202

502-852-7959 - Academic Office
502-588-4600 / 812-258-6120 - Patient Appointments

Clinical Expertise
Interventional Cardiology; High-Risk PCI; Percutaneous Adult Cardiac Structural Interventions; Stem Cell Therapies for Cardiac Regeneration; Heart Failure


Board Certifications

  • American Board of Internal Medicine -
    Cardiovascular Disease / Interventional Cardiology

Education and Training

  • Medical School: University of Louisville
  • Residency: Boston Medical Center
  • Fellowship: University of Louisville (Cardiology); Johns Hopkins University (Interventional Cardiology)


Recent Publications

      • Khan AR, Khan S, Riaz H, Luni FK, Simo H, Bin Abdulhak A, Bavishi C, Flaherty M. Efficacy and safety of transcatheter aortic valve replacement in intermediate surgical risk patients: A systematic review and meta-analysis. Catheter Cardiovasc Interv. 2016 Mar 4. doi: 10.1002/ccd.26465. [Epub ahead of print] PubMed PMID: 26946091.
      • Pant S, Patel S, Golwala H, Patel N, Pandey A, Badheka A, Angihotri K, Patel N, Deshmukh A, Flaherty MP. Transcatheter Aortic Valve Replacement Complication Rates in Teaching Vs Non-Teaching Centers in the United States. J Invasive Cardiol. 2016 Feb;28(2):67-70. PubMed PMID: 26841440.
      • Keith MC, Tokita Y, Tang XL, Ghafghazi S, Moore JB 4th, Hong KU, Elmore JB, Amraotkar AR, Guo H, Ganzel BL, Grubb KJ, Flaherty MP, Vajravelu BN, Wysoczynski M, Bolli R. Effect of the stop-flow technique on cardiac retention of c-kit positive human cardiac stem cells after intracoronary infusion in a porcine model of chronic ischemic cardiomyopathy. Basic Res Cardiol. 2015 Sep;110(5):503. doi: 10.1007/s00395-015-0503-8. Epub 2015 Jul 7. PubMed PMID: 26150250.
      • Flaherty MP, Grubb KJ. Transcatheter aortic valve replacement: focus on sex-related differences in outcomes. Am J Cardiovasc Drugs. 2015 Apr;15(2):95-101. doi: 10.1007/s40256-015-0110-y. Review. PubMed PMID: 25752476.
      • Flaherty MP, Sayfo S, Resar J. Transcatheter closure of five atrial septal communications in the presence of severe pulmonary arterial hypertension and severe left ventricular non-compliance. J Invasive Cardiol. 2015 Apr;27(4):E51-5. PubMed PMID: 25840408.
      • Flaherty MP, Mohsen A, Moore JB 4th, Bartoli CR, Schneibel E, Rawasia W, Williams ML, Grubb KJ, Hirsch GA. Predictors and clinical impact of pre-existing and acquired thrombocytopenia following transcatheter aortic valve replacement. Catheter Cardiovasc Interv. 2015 Jan 1;85(1):118-29. doi: 10.1002/ccd.25668. Epub 2014 Sep 30. PubMed PMID: 25204308.
      • Keith MC, Tang XL, Tokita Y, Li QH, Ghafghazi S, Moore Iv J, Hong KU, Elmore B, Amraotkar A, Ganzel BL, Grubb KJ, Flaherty MP, Hunt G, Vajravelu B, Wysoczynski M, Bolli R. Safety of intracoronary infusion of 20 million C-kit positive human cardiac stem cells in pigs. PLoS One. 2015 Apr 23;10(4):e0124227. doi: 10.1371/journal.pone.0124227. eCollection 2015. PubMed PMID: 25905721; PubMed Central PMCID: PMC4408046.
      • Bolli R, Birks E, Flaherty MP, Keith M, Ghafghazi S. Response to letter regarding article, "Cell therapy for heart failure: a comprehensive overview of experimental and clinical studies, current challenges, and future directions". Circ Res. 2014 Nov 7;115(11):e33-4. doi: 10.1161/CIRCRESAHA.114.305263. PubMed PMID: 25378533.
      • Leucker TM, Williams ML, Flaherty MP. Transcatheter aortic valve replacement: a novel abdominal transaortic approach. Catheter Cardiovasc Interv. 2014 Mar 1;83(4):670-5. doi: 10.1002/ccd.25252. Epub 2013 Dec 4. PubMed PMID: 24130126.
      • Bartoli CR, McCants KC, Birks EJ, Flaherty MP, Slaughter MS. Percutaneous closure of a patent foramen ovale to prevent paradoxical thromboembolism in a patient with a continuous-flow LVAD. J Invasive Cardiol. 2013 Mar;25(3):154-6. PubMed PMID: 23468448.